Search

Your search keyword '"Breton, J J"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Breton, J J" Remove constraint Author: "Breton, J J"
48 results on '"Breton, J J"'

Search Results

2. Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue

6. Protective factors and borderline personality disorder in adolescence

7. ChemInform Abstract: 1-Substituted 4-Aryl-5-pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency.

10. ChemInform Abstract: Bicyclic N‐Hydroxyurea Inhibitors of 5‐Lipoxygenase: Pharmacodynamic, Pharmacokinetic, and in vitro Metabolic Studies Characterizing N‐ Hydroxy‐N‐(2,3‐dihydro‐6‐(phenylmethoxy)‐3‐benzofuranyl)urea.

11. Prolonged hallucinations and dissociative self mutilation following use of Salvia divinorum in a bipolar adolescent girl.

12. Correlates of mental disorders in the Quebec general population of 6 to 14-year olds.

13. Complementary development of prevention and mental health promotion programs for Canadian children based on contemporary scientific paradigms.

14. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB<SUB>4</SUB>receptor antagonist with anti-inflammatory activity

15. Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.

16. 1-Substituted 4-Aryl-5-pyridinylimidazoles:  A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency

17. Bicyclic N-Hydroxyurea Inhibitors of 5-Lipoxygenase:  Pharmacodynamic, Pharmacokinetic, and in Vitro Metabolic Studies Characterizing N-Hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea

21. Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells.

22. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.

23. Quebec child mental health survey: prevalence of DSM-III-R mental health disorders.

24. Diagnostic Interview Schedule for Children (DISC-2.25) in Quebec: reliability findings in light of the MECA study.

25. The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB.

26. Production of biologically active human RelA (p65) in baculovirus-infected insect cells.

27. Do children aged 9 through 11 years understand the DISC Version 2.25 questions?

28. Informants, correlates and child disorders in a clinical population.

29. Industrial disaster and mental health of children and their parents.

30. Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production.

31. Weekly first-line chemotherapy of metastatic breast cancer with cyclophosphamide and epirubicin.

33. Pilot study for the Quebec Child Mental Health Survey: Part II. Correlates of DSM-III-R criteria among six to 14 year olds.

34. Pilot study for the Quebec Child Mental Health survey: Part I. Measurement of prevalence estimates among six to 14 year olds.

35. Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs.

36. [Asthma in children 4 to 6 years old].

37. [The humanization of medical care].

39. [Evaluation of care in child psychiatry. Results of an exploratory study].

41. [Asthma in very young children (14-30-months-old): allergic and psychological characteristics].

44. [Pediatric psychiatry and dermatology: presentation of a case of atopic dermatitis].

45. Follow-up study of 35 asthmatic preschool children.

48. [Infantile asthma: allergy and psychopathology. Preliminary remarks].

Catalog

Books, media, physical & digital resources